List of works - R Julian Preston

4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans.

scientific article published on November 2006

A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens ⬇️

scientific article published on May 18, 2011

A review of biomonitoring studies measuring genotoxicity in humans exposed to hair dyes

scientific article

An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.

scientific article

Application of key events analysis to chemical carcinogens and noncarcinogens

scientific article

Assessing human germ-cell mutagenesis in the Postgenome Era: a celebration of the legacy of William Lawson (Bill) Russell

scientific article

Bystander effects, genomic instability, adaptive response, and cancer risk assessment for radiation and chemical exposures

scientific article

Can radiation research impact the estimation of risk?

scientific article

Cancer risk assessment for 1,3-butadiene: data integration opportunities

scientific article

Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know ⬇️

scientific article published on November 10, 2003

Childhood acute lymphocytic leukemia and perspectives on risk assessment of early-life stage exposures

scientific article published on 16 October 2006

Children as a sensitive subpopulation for the risk assessment process

scientific article published in September 2004

Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization

scientific article

DNA Reactivity as a Mode of Action and Its Relevance to Cancer Risk Assessment ⬇️

scientific article published on October 19, 2012

DNA-reactive carcinogens: mode of action and human cancer hazard

scientific article

Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop

scientific article published on October 2013

Epigenetic processes and cancer risk assessment

scientific article published on 4 December 2006

Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice

scientific article

International organizations, risk assessment and research-Why, what and how.

scientific article

Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints

scientific article

Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001.

scientific article

Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data

scientific article

Quantitation of molecular endpoints for the dose-response component of cancer risk assessment

scientific article

Radiation biology: concepts for radiation protection

scientific article published on July 2004

Reciprocal translocations in somatic and germ cells of mice chronically exposed by inhalation to ethylene oxide: implications for risk assessment

scientific article

The LNT model is the best we can do—today

scientific article published on September 1, 2003

The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation

scientific article published on 07 June 2016

The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events

scientific article

The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene

scientific article

Toxicoproteomics and its application to human health risk assessment ⬇️

scientific article published on December 1, 2007

List of works by R Julian Preston

4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans.

A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens ⬇️

A review of biomonitoring studies measuring genotoxicity in humans exposed to hair dyes

An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.

Application of key events analysis to chemical carcinogens and noncarcinogens

Assessing human germ-cell mutagenesis in the Postgenome Era: a celebration of the legacy of William Lawson (Bill) Russell

Bystander effects, genomic instability, adaptive response, and cancer risk assessment for radiation and chemical exposures

Can radiation research impact the estimation of risk?

Cancer risk assessment for 1,3-butadiene: data integration opportunities

Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know ⬇️

Childhood acute lymphocytic leukemia and perspectives on risk assessment of early-life stage exposures

Children as a sensitive subpopulation for the risk assessment process

Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization

DNA Reactivity as a Mode of Action and Its Relevance to Cancer Risk Assessment ⬇️

DNA-reactive carcinogens: mode of action and human cancer hazard

Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop

Epigenetic processes and cancer risk assessment

Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice

International organizations, risk assessment and research-Why, what and how.

Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints

Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001.

Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data

Quantitation of molecular endpoints for the dose-response component of cancer risk assessment

Radiation biology: concepts for radiation protection

Reciprocal translocations in somatic and germ cells of mice chronically exposed by inhalation to ethylene oxide: implications for risk assessment

The LNT model is the best we can do—today

The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation

The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events

The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene

Toxicoproteomics and its application to human health risk assessment ⬇️